Directory
>
Amy Mccarte-Roshak
Amy Mccarte-Roshak
VP Development and Oncology Portfolio | GSK
Pennsylvania, United States
Amy Mccarte-Roshak
Summary
Amy Mccarte-Roshak is an accomplished executive in the pharmaceutical industry, currently serving as the VP of Development and Oncology Portfolio at The Janssen Pharmaceutical Companies of Johnson & Johnson. With a robust background in biotechnology and clinical development, she has a proven track record in drug discovery and development. Her strategic leadership in oncology has positioned her as a key player in advancing innovative therapies. Prior to her current role, Amy led strategy and business operations at GlaxoSmithKline, where she honed her expertise in alternative discovery and development. She is passionate about leveraging her knowledge to drive impactful changes in the life sciences sector. Amy's ability to navigate complex challenges in the pharmaceutical landscape showcases her adaptability and resilience. Her commitment to excellence and innovation makes her a respected figure in her field. Outside of her professional endeavors, she likely engages in continuous learning to stay abreast of emerging trends in healthcare.
Amy Mccarte-Roshak
Work Experience
VP Development and Oncology Portfolio at
The Janssen Pharmaceutical Companies of Johnson & Johnson
May 2019 - Present
Head, Strategy & Business Operations, Alternative Discovery & Development at
GSK
January 2012 - Present
Frequently Asked Questions about Amy Mccarte-Roshak
What is Amy Mccarte-Roshak email address?
Amy Mccarte-Roshak's primary email address is ******************@gsk.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Amy Mccarte-Roshak work for?
Amy Mccarte-Roshak is a VP Development and Oncology Portfolio at GSK, a company specializing in Pharmaceutical & Medicine Manufacturing.
How can I directly contact Amy Mccarte-Roshak?
To contact Amy Mccarte-Roshak directly, you can use the email address ******************@gsk.com. Complete contact information is available upon registration with Muraena.
Who is Amy Mccarte-Roshak?
Amy Mccarte-Roshak is an accomplished executive in the pharmaceutical industry, currently serving as the VP of Development and Oncology Portfolio at The Janssen Pharmaceutical Companies of Johnson & Johnson. With a robust background in biotechnology and clinical development, she has a proven track record in drug discovery and development. Her strategic leadership in oncology has positioned her as a key player in advancing innovative therapies. Prior to her current role, Amy led strategy and business operations at GlaxoSmithKline, where she honed her expertise in alternative discovery and development. She is passionate about leveraging her knowledge to drive impactful changes in the life sciences sector. Amy's ability to navigate complex challenges in the pharmaceutical landscape showcases her adaptability and resilience. Her commitment to excellence and innovation makes her a respected figure in her field. Outside of her professional endeavors, she likely engages in continuous learning to stay abreast of emerging trends in healthcare.
Amy`s contact details
******************@gsk.com
Colleagues
Medical Executive Director - Oncology Russia and Cis
President, North America
Bank of America, VP, Network Automation & Telemetry, Global Technology
Non-Executive Director, Member Of Audit And Risk, Remuneration Committees
Director, State Government Relations-New England & NY
Managing Partner
Member, Board of Trustees